1. Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes. Issue 10 (11th August 2020) Authors: Pribyl, Miroslav; Hubackova, Sona; Moudra, Alena; Vancurova, Marketa; Polackova, Helena; Stopka, Tomas; Jonasova, Anna; Bokorova, Radka; Fuchs, Ota; Stritesky, Jan; Salovska, Barbora; Bartek, Jiri; Hodny, Zdenek Journal: Molecular oncology Issue: Volume 14:Issue 10(2020) Page Start: 2403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia. Issue 7 (12th April 2013) Authors: Sarova, Iveta; Brezinova, Jana; Zemanova, Zuzana; Bystricka, Dagmar; Krejcik, Zdenek; Soukup, Petr; Vydra, Jan; Cermak, Jaroslav; Jonasova, Anna; Michalova, Kyra Journal: Genes, chromosomes & cancer Issue: Volume 52:Issue 7(2013:Jul.) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes. (March 2016) Authors: Svobodova, Karla; Zemanova, Zuzana; Lhotska, Halka; Novakova, Milena; Podskalska, Lucie; Belickova, Monika; Brezinova, Jana; Sarova, Iveta; Izakova, Silvia; Lizcova, Libuse; Berkova, Adela; Siskova, Magda; Jonasova, Anna; Cermak, Jaroslav; Michalova, Kyra Journal: Leukemia research Issue: Volume 42(2016:Mar.) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution. Issue 7 (25th March 2020) Authors: Svobodova, Karla; Lhotska, Halka; Hodanova, Lucie; Pavlistova, Lenka; Vesela, Denisa; Belickova, Monika; Vesela, Jitka; Brezinova, Jana; Sarova, Iveta; Izakova, Silvia; Lizcova, Libuse; Siskova, Magda; Jonasova, Anna; Cermak, Jaroslav; Michalova, Kyra; Zemanova, Zuzana Journal: Genes, chromosomes & cancer Issue: Volume 59:Issue 7(2020) Page Start: 396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome. (24th July 2017) Authors: Valka, Jan; Vesela, Jitka; Votavova, Hana; Dostalova‐Merkerova, Michaela; Horakova, Zuzana; Campr, Vit; Brezinova, Jana; Zemanova, Zuzana; Jonasova, Anna; Cermak, Jaroslav; Belickova, Monika Journal: European journal of haematology Issue: Volume 99:Number 4(2017) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine. (2nd October 2016) Authors: Moudra, Alena; Hubackova, Sona; Machalova, Veronika; Vancurova, Marketa; Bartek, Jiri; Reinis, Milan; Hodny, Zdenek; Jonasova, Anna Journal: Oncoimmunology Issue: Volume 5:Number 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genome‐wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide. (11th November 2014) Authors: Merkerova, Michaela Dostalova; Krejcik, Zdenek; Belickova, Monika; Hrustincova, Andrea; Klema, Jiri; Stara, Eliška; Zemanova, Zuzana; Michalova, Kyra; Cermak, Jaroslav; Jonasova, Anna Journal: European journal of haematology Issue: Volume 95:Number 1(2015:Jul.) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype. (May 2018) Authors: Sarova, Iveta; Brezinova, Jana; Zemanova, Zuzana; Ransdorfova, Sarka; Svobodova, Karla; Izakova, Silvia; Pavlistova, Lenka; Lizcova, Libuse; Berkova, Adela; Skipalova, Karolina; Hodanova, Lucie; Salek, Cyril; Jonasova, Anna; Michalova, Kyra Journal: Leukemia research Issue: Volume 68(2018) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. High level of full‐length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide. (31st October 2014) Authors: Jonasova, Anna; Bokorova, Radka; Polak, Jaroslav; Vostry, Martin; Kostecka, Arnost; Hajkova, Hana; Neuwirtova, Radana; Siskova, Magda; Sponerova, Dana; Cermak, Jaroslav; Mikulenkova, Dana; Cervinek, Libor; Brezinova, Jana; Michalova, Kyra; Fuchs, Ota Journal: European journal of haematology Issue: Volume 95:Number 1(2015:Jul.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). (June 2018) Authors: Jonasova, Anna; Neuwirtova, Radana; Polackova, Helena; Siskova, Magda; Stopka, Tomas; Cmunt, Eduard; Belickova, Monika; Moudra, Alena; Minarik, Lubomir; Fuchs, Ota; Michalova, Kyra; Zemanova, Zuzana Journal: Leukemia research Issue: Volume 69(2018) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗